BCP Partnering Portal / ScreenIn3D
ScreenIn3D
Company Type:
Manufacturer
Business Address:
Technology and Innovation Centre
99 George Street
Glasgow
G1 1RD
United Kingdom
99 George Street
Glasgow
G1 1RD
United Kingdom
Phone:
+44 141 444 7368
Website:
Company Overview:
ScreenIn3D is a company that utilizes the latest advances in lab-on-a-chip and 3D culture techniques to develop a unique screening platform for accelerating and making efficient drug discovery processes. The company's platform enables the testing of drug efficacy on predictive 3D human models of disease at scale, allowing for faster and more accurate testing of small molecules, biologics, cell, and gene therapies. ScreenIn3D's technology generates large data sets with rare or small samples, mimics human disease environments, and allows for customer-defined assays, making it a valuable tool for pharmaceutical companies and researchers in the field of drug discovery.
About Us:
ScreenIn3D is a start-up company co-founded by Michele Zagnoni and Alex Sim in 2018. The company is based in the Technology and Innovation Centre at the University of Strathclyde. ScreenIn3D utilises the latest advances in microfluidics and 3D culture to develop a unique microfluidic screening platform.
Using our propriety ONCO-Chip3D technology – ScreenIn3D offers high quality pre-clinical screening services to biotech and pharmaceutical companies with interest in developing new oncology assays. This helps provide our customers with the confidence to take a leap forward to advanced stages of drug approval.
The unique combination of microfluidic lab-on-a-chip technology with physiologically relevant 3D cancer models is designed to make drug discovery more closely relevant with what happens in the body. The ability to micro size drug-cell interactions will allow pharmaceutical and biotech companies do 100x more testing for the same money spent as well as increasing productivity as it enables more experiments to be done on the same platform at the same time.
Applications, Products & Services:
Combines microfluidic lab-on-a-chip technology with physiologically relevant multicellular spheroids to enable formation and long-term culture of 3D tumor models for drug screening and individualized chemosensitivity testing.
Targeted drug discovery and development
Allows companies to do 1000x more testing for the same spend
Facilitating combination therapy for better disease management
Provides a robust, time-effective platform for personalised medicine
Year Established:
2018
Industry:
Life Sciences
Pharma & Biotech
Scientific Services
Products, Services & Applications:
Cell Culture/Tissue Culture
Services: Drug Discovery
Microfluidics
Official Distributors:
AMS Biotechnology Ltd (AMSBIO) (United Kingdom)
The BCP Partnering Portal
Where Manufacturers and Channel Partners / Distributors find each other!
- You are currently viewing the company snapshot 'ScreenIn3D'
- If you work for this company, you can use the 'Claim Company' button above to link it to your account.
- The BCP Partnering Portal is a specialized matchmaking platform featuring over 28,000 company profiles, who supply products and services within scientific fields. It serves as a crucial resource for facilitating B2B partnerships between manufacturers and channel partners.
- Developed by BioChannel Partners Ltd, an award-winning B2B partnering company with over 22 years of expertise in connecting manufacturers and channel partners of scientific products, the portal ensures that company profiles are kept up-to-date by both the BCP team and verified profile owners.
- This continuous update process ensures that users have access to accurate and current information, enhancing the platform's effectiveness in fostering successful business collaborations.
- Take advantage of this resource and join to manage your own company profile and search for new partners.